期刊文献+

RP-HPLC法测定盐酸帕罗西汀片的含量 被引量:6

Determination of proxetine hydrochloride tablets by RP-HPLC
下载PDF
导出
摘要 目的 :建立测定盐酸帕罗西汀片中盐酸帕罗西汀含量的反相高效液相色谱法。方法 :采用 CL S- ODS柱 (15 0 mm× 6 .0mm I.D) ,甲醇 - p H 4.5 0 .0 5 m ol/ L醋酸钠缓冲液 (6 5∶ 35 )为流动相 ,用紫外检测器于 2 95 nm波长处检测。结果 :平均回收率为 10 0 .5 % ,RSD为 0 .82 % ,n=5。线性范围为 0 .10~ 0 .5 0 m g/ m L (r=0 .9999)。结论 :本法具有简便、快速、准确、可靠等优点 。 Objective:To establish a RP HPLC method for the determination of proxetine hydrochloride in its tablets.Methods:Proxetine hydrochloride can be separated on CLC ODS column with a mixture of methonal and pH 4.5 0.05 mol/L sodium acetate buffer (65∶35) as mobile phase and detected at 295 nm.The flow rate was 1.5 mL/min.Results:The standard curve was linear between 0.10 mg/mL and 0.50 mg/mL and the correlation coefficient was 0.9999 .The average recovery and relative standard deviation were 100.5% and 0.82% respectively.Conclusion:The method for the determination of proxetine hydrochloride in its pharmaceutical substances and tablets is simple,rapid,accurate and reliable.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2001年第3期233-234,共2页 Chinese Journal of Modern Applied Pharmacy
关键词 反相高效液相色谱法 盐酸帕罗西汀片 帕罗西汀 含量测定 RP HPLC paroxetine hydrochloride tablet paroxetine
  • 相关文献

参考文献1

二级参考文献19

  • 1Boyer WF, Feighner JP. Pharmacokinetics and drug interactions. In: Boyer WF, Feighner JP, eds. Selective Serotonin Reuptake Inhibitors. Chichester P John Wiley.1991,b:81.
  • 2Anderson BB,Mikkelson M,Vesterager A, et al. No influence of the antidepressant paroxetin on carbamazepine, valproate and phenytoin. Epilepsy Research, 1991,10(2-3):201.
  • 3Apseloff G, Wilner KD, Von Deutsh DA, et al. Sertraline does not alter steady-state concentrations or renal clearance of lithium in healthy vonlunteers. J Clin Pharmacol, 1992,32(7):643.
  • 4Dominguez RA, Kumar AM, Cua W. Lack of change in fluoxetine and norfluoxetine kinetics when switching from fluoxetine to paroxetine. J Clin Psychopharmacol, 1996,16(4):320.
  • 5Preskom S. Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetinc,paroxetine and sertraline. Int Clin Psychopharmacol,1994,9 Supp1 3:13.
  • 6Baumann P. Pharmacokinetic-pharmacodynamic relationship of theselective serotonin reuptake inhibitors. Clin Pharmacokinet,1996,31(6):444.
  • 7Harvey AT. Cytochrome P450 enzymes : interpretation of their interactions with selective serotonin reuptake inhibitors. Part 1. J Clin Psychopharmacol,1996,16(4):273.
  • 8Harvey AT. Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part 2. J Clin Psychopharmacol,1996,16(5):345.
  • 9Nemeroff CB, Devane CL, Pollock BG. Newer antipressants and the cytochrome P450 system. Am J Psychiatry,1996, 153(3):311.
  • 10Levinson ML, Lipsy RJ, Fuller Dk. Advers effects and drug interactions associated with fluoxetine therapy.DICP, 1991,25(11):1273.

共引文献12

同被引文献39

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部